CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Zentalis Grants Stock Options for 136,000 Shares to Four New Employees

By Public Technologies
  • Zentalis Pharmaceuticals granted non-qualified stock options covering 136,000 shares to four newly hired employees on November 2, 2026.
  • The options carry a 10-year term under the 2022 Employment Inducement Incentive Award Plan.
  • Vesting spans four years: 25% on the first anniversary of the vesting commencement date, with 75% vesting monthly over the next three years.
  • Each vesting installment requires continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021700PRIMZONEFULLFEED9868546) on November 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk